165 results
424B5
NAVB
Navidea Biopharmaceuticals, Inc.
28 Apr 23
Prospectus supplement for primary offering
10:55am
Biotechnology Innovation Organization, Society of Nuclear Medicine and Molecular Imaging (“SNMMI”), and The American College of Rheumatology (“ACR … (“TB”)
In April 2019, the Company announced that Professor Mike Sathekge, MBChB, M. Med (Nuclear Medicine), PhD, Professor and Head of the Department
424B4
lbsyf1arseix
4 Aug 22
Prospectus supplement with pricing info
1:03pm
8-K
EX-99.3
5z68v4fd4
16 Dec 21
Navidea Biopharmaceuticals Terminates Stock Purchase Agreement
4:46pm
424B3
wx6vcr
24 May 21
Prospectus supplement
4:02pm